Search for

    Search Results


    Irish Professor: 65% of supplements do not live up to their claims

    Groundbreaking research

    Two particular studies conducted with Pharma Nord’s preparations have demonstrated a hitherto unknown health potential for nutritional supplements. One is the groundbreaking KiSel-10 study that was published in the International Journal of Cardiology in 2013. The other one is named Q-Symbio and was published in 2014 in JACC Heart Failure. 

    In a new study where coenzyme Q10 supplements will be given to COVID-19 patients with long-term effects of the virus, the scientists have specifically asked Pharma Nord to provide the Q10 preparations, because it is the only Danish company that also manufactures coenzyme Q10 as a licensed drug.